A case of anti-SAE antibody-positive dermatomyositis presenting with preceding panniculitis as the initial symptom

Myositis-specific autoantibodies found in dermatomyositis (DM) are associated with clinical symptoms and responses to therapy and are useful for diagnosis, treatment selection, and prognostication. Although the prevalence of anti-small ubiquitin-like modifier-activating enzyme (anti-SAE) antibodies in DM patients is low, clinical features such as skin symptoms preceding muscle symptoms and a higher incidence of dysphagia and malignancy have been reported. Herein, we present a case of anti-SAE antibody-positive DM in which panniculitis of the lower legs, a rare dermatological manifestation of DM, preceded muscle symptoms by 2 months. This case was associated with cervical cancer; however, the clinical course of DM was favourable with glucocorticoid monotherapy. Anti-SAE antibody-positive DM needs to be considered as a differential diagnosis of unexplained panniculitis without muscle symptoms.

Authors

Institutions

Publication Details

Journal
Modern Rheumatology Case Reports
Published
2025-01-01
DOI
https://doi.org/10.1093/mrcr/rxaf029
Primary Topic
Inflammatory Myopathies and Dermatomyositis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A case of anti-SAE antibody-positive dermatomyositis presenting with preceding panniculitis as the initial symptom

Hitoshi Yamasaki, Jun Ishizaki, Kenta Horie, Daisuke Hiraoka et al.
Modern Rheumatology Case Reports
Inflammatory Myopathies and Dermatomyositis
article

A case of anti-SAE antibody-positive dermatomyositis presenting with preceding panniculitis as the initial symptom

Hitoshi Yamasaki, Jun Ishizaki, Kenta Horie, Daisuke Hiraoka, Koichiro Suemori, Jun Muto, Takuya Matsumoto, Hitoshi Hasegawa, Katsuto Takenaka, Erika Horimoto, Satoshi Yoshida
article en

Abstract

Myositis-specific autoantibodies found in dermatomyositis (DM) are associated with clinical symptoms and responses to therapy and are useful for diagnosis, treatment selection, and prognostication. Although the prevalence of anti-small ubiquitin-like modifier-activating enzyme (anti-SAE) antibodies in DM patients is low, clinical features such as skin symptoms preceding muscle symptoms and a higher incidence of dysphagia and malignancy have been reported. Herein, we present a case of anti-SAE antibody-positive DM in which panniculitis of the lower legs, a rare dermatological manifestation of DM, preceded muscle symptoms by 2 months. This case was associated with cervical cancer; however, the clinical course of DM was favourable with glucocorticoid monotherapy. Anti-SAE antibody-positive DM needs to be considered as a differential diagnosis of unexplained panniculitis without muscle symptoms.

Modern Rheumatology Case ReportsVol. 9(2)
Numazu City Hospital (JP), Saiseikai Ibaraki Hospital (JP), Ehime University (JP)
Good health and well-being
Openalex Percentile: Top 82%
Inflammatory Myopathies and Dermatomyositis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.